Lineage Cell Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2014
Total Assets: $74.9M
Liabilities Breakdown FY2014
Total Liabilities: $38.4M
Asset Breakdown
Total Assets: $74.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $29.5M | 39.4% |
| Accounts Receivable | $549.0K | 0.7% |
| Inventory | $266.0K | 0.4% |
| Property, Plant & Equipment | $2.9M | 3.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $38.8M | 51.9% |
| Other Assets | $2.9M | 3.9% |
Liabilities Breakdown
Total Liabilities: $38.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.3M | 6.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $36.1M | 94.0% |